Sign up to save your podcasts
Or
Share HER2-Low and HER2-Ultralow Breast Cancer — A Roundtable Discussion on Current and Future Management Strategies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
HER2-Low and HER2-Ultralow Breast Cancer — A Roundtable Discussion on Current and Future Management Strategies
Dr Joyce O’Shaughnessy from Sarah Cannon Research Institute in Dallas, Texas, Dr Mark D Pegram from Stanford Cancer Institute in California, and Prof Peter Schmid from Barts Cancer Institute in London, United Kingdom, summarize currently available data guiding treatment decision-making for patients with low and ultralow HER2 expression and present cases from their practices.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.3
6060 ratings
Dr Joyce O’Shaughnessy from Sarah Cannon Research Institute in Dallas, Texas, Dr Mark D Pegram from Stanford Cancer Institute in California, and Prof Peter Schmid from Barts Cancer Institute in London, United Kingdom, summarize currently available data guiding treatment decision-making for patients with low and ultralow HER2 expression and present cases from their practices.
CME information and select publications here.
More shows like Breast Cancer Update
View all
Gastrointestinal Cancer Update
17 Listeners
Lung Cancer Update
32 Listeners
Prostate Cancer Update
15 Listeners
The People's Pharmacy
989 Listeners
Gynecologic Oncology Update
12 Listeners
Hematologic Oncology Update
73 Listeners
Dermatologic Oncology Update
0 Listeners
Research To Practice | Oncology Videos
110 Listeners
FoundMyFitness
5,292 Listeners
JAMA Clinical Reviews
478 Listeners
Hidden Brain
43,270 Listeners
The ONS Podcast
196 Listeners
Dhru Purohit Show
3,485 Listeners
The Peter Attia Drive
7,814 Listeners
Oncology Today with Dr Neil Love
55 Listeners
Huberman Lab
28,250 Listeners
ZOE Science & Nutrition
1,925 Listeners
Two Onc Docs
165 Listeners